1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Healthcare Expenditure
4.2.2. Growing Use of Point-of-Care (PoC) Diagnostic Tests
4.2.3. Technical Advancements in Molecular Diagnostics
4.2.4. Increasing Funding for R&D of Molecular Diagnostics Products
4.3. Restraints
4.3.1. Stringent Regulatory Framework
4.3.2. High Cost of Molecular Diagnostic Tests
4.4. Opportunities
4.4.1. Increasing Focus on Companion Diagnostics to Offer New Growth Potential
4.5. Challenges
4.5.1. Lack of Skilled Professionals
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Porter’s Five Forces Analysis
5. Asia-Pacific Molecular Diagnostics Market Assessment—by Product & Service
5.1. Overview
5.2. Kits & Reagents
5.3. Instruments
5.4. Software & Services
6. Asia-Pacific Molecular Diagnostics Market Assessment—by Test Type
6.1. Overview
6.2. Laboratory Tests
6.3. Point-of-Care Tests
7. Asia-Pacific Molecular Diagnostics Market Assessment—by Technology
7.1. Overview
7.2. Polymerase Chain Reaction (PCR)
7.3. In Situ Hybridization (ISH)
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Microarrays
7.6. Sequencing
7.7. Mass Spectrometry
7.8. Other Technologies
8. Asia-Pacific Molecular Diagnostics Market Assessment—by Application
8.1. Overview
8.2. Infectious Diseases
8.2.1. COVID-19
8.2.2. Hepatitis
8.2.3. HIV
8.2.4. Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG)
8.2.5. Human Papillomavirus (HPV)
8.2.6. Tuberculosis
8.2.7. Influenza
8.2.8. Healthcare-associated Infections (HAIs)
8.2.9. Other Infectious Diseases
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Lung Cancer
8.3.4. Prostate Cancer
8.3.5. Lymphoma
8.3.6. Leukemia
8.3.7. Cervical Cancer
8.3.8. Other Cancer Types
8.4. Genetic Testing
8.5. Neurological Diseases
8.6. Cardiovascular Diseases
8.7. Other Applications
9. Asia-Pacific Molecular Diagnostics Market Assessment—by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Asia-Pacific Molecular Diagnostics Market Assessment—by Country/Region
10.1. Overview
10.2. China
10.3. India
10.4. Japan
10.5. Australia
10.6. Singapore
10.7. Indonesia
10.8. Malaysia
10.9. South Korea
10.10. New Zealand
10.11. Rest of Asia-Pacific
11. Competitive Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis, by Key Player/Key Market Ranking, 2022
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. F. Hoffmann-La Roche Ltd.
12.2. Hologic, Inc.
12.3. QIAGEN N.V.
12.4. Danaher Corporation
12.5. bioMérieux S.A.
12.6. Becton, Dickinson and Company (BD)
12.7. Siemens Healthineers AG
12.8. DiaSorin S.p.A.
12.9. Abbott Laboratories
12.10. Thermo Fisher Scientific Inc.
12.11. Agilent Technologies, Inc.
12.12. Illumina, Inc.
12.13. Seegene, Inc.
(Note: SWOT analysis will be provided for the top 5 players only)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Asia-Pacific Molecular Diagnostics Market, by Product & Service, 2021–2030 (USD Million)
Table 2 Asia-Pacific Molecular Diagnostics Kits & Reagents Market, by Country/Region, 2021–2030 (USD Million)
Table 3 Asia-Pacific Molecular Diagnostics Instruments Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Asia-Pacific Molecular Diagnostics Software & Services Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Asia-Pacific Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 6 Asia-Pacific Molecular Diagnostics for Laboratory Tests, by Country/Region, 2021–2030 (USD Million)
Table 7 Asia-Pacific Molecular Diagnostics for Point-of-Care Tests, by Country/Region, 2021–2030 (USD Million)
Table 8 Asia-Pacific Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 9 Asia-Pacific Molecular Diagnostics for Polymerase Chain Reaction (PCR), by Country/Region, 2021–2030 (USD Million)
Table 10 Asia-Pacific Molecular Diagnostics for In Situ Hybridization (ISH), by Country/Region, 2021–2030 (USD Million)
Table 11 Asia-Pacific Molecular Diagnostics for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2021–2030 (USD Million)
Table 12 Asia-Pacific Molecular Diagnostics for Microarrays, by Country/Region, 2021–2030 (USD Million)
Table 13 Asia-Pacific Molecular Diagnostics for Mass Spectrometry, by Country/Region, 2021–2030 (USD Million)
Table 14 Asia-Pacific Molecular Diagnostics for Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 15 Asia-Pacific Other Technologies Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Asia-Pacific Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 17 Asia-Pacific Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 18 Asia-Pacific Molecular Diagnostics Market for Infectious Diseases Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Asia-Pacific Molecular Diagnostics Market for COVID-19, by Country/Region, 2021–2030 (USD Million)
Table 20 Asia-Pacific Molecular Diagnostics Market for Hepatitis, by Country/Region, 2021–2030 (USD Million)
Table 21 Asia-Pacific Molecular Diagnostics Market for HIV, by Country/Region, 2021–2030 (USD Million)
Table 22 Asia-Pacific Molecular Diagnostics Market for CT/NG, by Country/Region, 2021–2030 (USD Million)
Table 23 Asia-Pacific Molecular Diagnostics Market for Human papillomavirus (HPV), by Country/Region, 2021–2030 (USD Million)
Table 24 Asia-Pacific Molecular Diagnostics Market for Tuberculosis, by Country/Region, 2021–2030 (USD Million)
Table 25 Asia-Pacific Molecular Diagnostics Market for Influenza, by Country/Region, 2021–2030 (USD Million)
Table 26 Asia-Pacific Molecular Diagnostics Market for Healthcare-associated Infections (HAIs), by Country/Region, 2021–2030 (USD Million)
Table 27 Asia-Pacific Molecular Diagnostics Market for Other Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 28 Asia-Pacific Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 29 Asia-Pacific Molecular Diagnostics Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 30 Asia-Pacific Molecular Diagnostics Market for Breast Cancer, by Country/Region, 2021–2030 (USD Million)
Table 31 Asia-Pacific Molecular Diagnostics Market for Colorectal Cancer, by Country/Region, 2021–2030 (USD Million)
Table 32 Asia-Pacific Molecular Diagnostics Market for Lung Cancer, by Country/Region, 2021–2030 (USD Million)
Table 33 Asia-Pacific Molecular Diagnostics Market for Prostate Cancer, by Country/Region, 2021–2030 (USD Million)
Table 34 Asia-Pacific Molecular Diagnostics Market for Lymphoma, by Country/Region, 2021–2030 (USD Million)
Table 35 Asia-Pacific Molecular Diagnostics Market for Leukemia, by Country/Region, 2021–2030 (USD Million)
Table 36 Asia-Pacific Molecular Diagnostics Market for Cervical Cancer, by Country/Region, 2021–2030 (USD Million)
Table 37 Asia-Pacific Molecular Diagnostics Market for Other Cancer Types, by Country/Region, 2021–2030 (USD Million)
Table 38 Asia-Pacific Molecular Diagnostics Market for Genetic Testing, by Country/Region, 2021–2030 (USD Million)
Table 39 Asia-Pacific Molecular Diagnostics Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 40 Asia-Pacific Molecular Diagnostics Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 41 Asia-Pacific Molecular Diagnostics Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 42 Asia-Pacific Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 43 Asia-Pacific Molecular Diagnostics Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 44 Asia-Pacific Molecular Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 45 Asia-Pacific Molecular Diagnostics Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 46 Asia-Pacific Molecular Diagnostics Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 47 Asia-Pacific: Molecular Diagnostics Market, by Country/Region, 2021–2030 (USD Million)
Table 48 China: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 49 China: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 50 China: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 51 China: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 52 China: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 53 China: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 54 China: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 55 Japan: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 56 Japan: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 57 Japan: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 58 Japan: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 59 Japan: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 60 Japan: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 61 Japan: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 62 India: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 63 India: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 64 India: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 65 India: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 66 India: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 67 India: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 68 India: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 69 Australia: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 70 Australia: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 71 Australia: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 72 Australia: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 73 Australia: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 74 Australia: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 75 Australia: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 76 Singapore: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 77 Singapore: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 78 Singapore: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 79 Singapore: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 80 Singapore: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 81 Singapore: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 82 Singapore: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 83 Indonesia: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 84 Indonesia: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 85 Indonesia: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 86 Indonesia: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 87 Indonesia: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 88 Indonesia: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 89 Indonesia: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 90 Malaysia: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 91 Malaysia: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 92 Malaysia: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 93 Malaysia: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 94 Malaysia: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 95 Malaysia: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 96 Malaysia: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 97 South Korea: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 98 South Korea: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 99 South Korea: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 100 South Korea: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 101 South Korea: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 102 South Korea: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 103 South Korea: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 104 New Zealand: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 105 New Zealand: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 106 New Zealand: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 107 New Zealand: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 108 New Zealand: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 109 New Zealand: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 110 New Zealand: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 111 Rest of Asia-Pacific: Molecular Diagnostics Market, by Product, 2021–2030 (USD Million)
Table 112 Rest of Asia-Pacific: Molecular Diagnostics Market, by Test Type, 2021–2030 (USD Million)
Table 113 Rest of Asia-Pacific: Molecular Diagnostics Market, by Technology, 2021–2030 (USD Million)
Table 114 Rest of Asia-Pacific: Molecular Diagnostics Market, by Application, 2021–2030 (USD Million)
Table 115 Rest of Asia-Pacific: Molecular Diagnostics Market for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 116 Rest of Asia-Pacific: Molecular Diagnostics Market for Oncology, by Type, 2021–2030 (USD Million)
Table 117 Rest of Asia-Pacific: Molecular Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 118 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Estimation
Figure 7 Asia-Pacific Molecular Diagnostics Market, by Product/Service, 2024–2030 (USD Million)
Figure 8 Asia-Pacific Molecular Diagnostics Market, by Test Type, 2024–2030 (USD Million)
Figure 9 Asia-Pacific Molecular Diagnostics Market, by Technology, 2024–2030 (USD Million)
Figure 10 Asia-Pacific Molecular Diagnostics Market, by Application, 2024–2030 (USD Million)
Figure 11 Asia-Pacific Molecular Diagnostics Market, by End User, 2024–2030 (USD Million)
Figure 12 Asia-Pacific Molecular Diagnostics Market, by Country/Region
Figure 13 Market Dynamics: Asia-Pacific Molecular Diagnostics Market
Figure 14 Asia-Pacific Molecular Diagnostics Market, by Product/Service, 2024 Vs. 2030 (USD Million)
Figure 15 Asia-Pacific Molecular Diagnostics Market, by Test Type, 2024 Vs. 2030 (USD Million)
Figure 16 Asia-Pacific Molecular Diagnostics Market, by Technology, 2024 Vs. 2030 (USD Million)
Figure 17 Asia-Pacific Molecular Diagnostics Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 18 Asia-Pacific Molecular Diagnostics Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 19 Asia-Pacific Molecular Diagnostics Market, by Country/Region, 2024 Vs. 2030 (USD Million)
Figure 20 Asia-Pacific Molecular Diagnostics Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 22 Asia-Pacific Molecular Diagnostics Market: Competitive Benchmarking, by Type
Figure 23 Asia-Pacific Molecular Diagnostics Market: Competitive Dashboard
Figure 24 Asia-Pacific Molecular Diagnostics Market: Market Share Analysis (2022)
Figure 25 F. Hoffmann-La Roche Ltd: Financial Snapshot, 2022
Figure 26 Hologic, Inc.: Financial Snapshot, 2022
Figure 27 QIAGEN N.V.: Financial Snapshot, 2022
Figure 28 Danaher Corporation: Financial Snapshot, 2022
Figure 29 BioMérieux S.A.: Financial Snapshot 2022
Figure 30 Becton, Dickinson and Company: Financial Snapshot, 2022
Figure 31 Siemens Healthineers AG: Financial Snapshot, 2022
Figure 32 DiaSorin S.p.A.: Financial Snapshot, 2022
Figure 33 Abbott Laboratories: Financial Snapshot, 2022
Figure 34 Thermo Fisher Scientific Inc.: Financial Snapshot, 2022
Figure 35 Agilent Technologies, Inc.: Financial Snapshot, 2022
Figure 36 Illumina, Inc.: Financial Snapshot, 2022
Figure 37 Seegene, Inc.: Financial Snapshot, 2022